Showing results (451-460 of 1,193) with videos related to

Sort By:
Pageof 120
JACC. Heart Failure|February 5, 2015
Heart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)G Michael Felker, Javed Butler, Sean P Collins, et al.
JACC. Heart Failure|June 16, 2014
Charting a roadmap for heart failure biomarker studiesTariq Ahmad, Mona Fiuzat, Michael J Pencina, et al.
JACC. Heart Failure|May 19, 2023
Pre-Heart Failure Longitudinal Change in a Hispanic/Latino Population-Based Study: Insights From the Echocardiographic Study of LatinosToshiki Kuno, Nestor Vasquez, Ayana K April-Sanders, et al.
JACC. Heart Failure|June 23, 2014
Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET Study Cohort (Targeted Left Ventricular Lead Placement to guide Cardiac Resynchronization Therapy)Anna C Kydd, Fakhar Z Khan, William D Watson, et al.
JACC. Heart Failure|June 23, 2014
The burden of acute heart failure on U.S. emergency departmentsAlan B Storrow, Cathy A Jenkins, Wesley H Self, et al.
JACC. Heart Failure|June 23, 2014
Long-term mortality after cardiac allograft vasculopathy: implications of percutaneous interventionShikhar Agarwal, Akhil Parashar, Samir R Kapadia, et al.
JACC. Heart Failure|May 25, 2023
Long-Term Exposure to Road Traffic Noise and Incident Heart Failure: Evidence From UK BiobankTeng Yang, Xin Hu, Jiawei Wang, et al.
JACC. Heart Failure|July 13, 2020
Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart FailureFeriha Bilgen, Peiyu Chen, Armella Poggi, et al.
JACC. Heart Failure|July 13, 2020
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF TrialScott D Solomon, Pardeep S Jhund, Brian L Claggett, et al.
JACC. Heart Failure|August 13, 2022
Angiotensinogen: More Than its Downstream Products: Evidence From Population Studies and Novel TherapeuticsTanvir Kahlon, Samantha Carlisle, Diana Otero Mostacero, et al.
Pageof 120